Martin Mueller

Title: Martin Mueller - Innovator in Photodynamic Therapy

Introduction

Martin Mueller is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of photodynamic therapy through his innovative research and development of novel compounds.

Latest Patents

Martin holds 2 patents that focus on 9-substituted porphycenes. His latest patents include compounds that are useful in photodynamic therapy, specifically designed to enhance the effectiveness of this treatment. The first patent details novel 9-substituted porphycene compounds, while the second patent describes porphycene compounds characterized by the formula ##STR1##, where each R is --(CH.sub.2).sub.n --X, with n ranging from 1 to 10. In this formula, X is OR.sup.1, and R.sup.1 can be alkyl, aralkyl, or aryl, making these compounds valuable as photosensitizers in photodynamic therapy.

Career Highlights

Martin is currently employed at Cytopharm, Inc., where he continues to advance his research in photodynamic therapy. His work has positioned him as a key figure in the development of therapeutic solutions that leverage the unique properties of porphycenes.

Collaborations

Throughout his career, Martin has collaborated with esteemed colleagues, including Emanuel Vogel and Otto Halpern. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Martin Mueller's contributions to the field of photodynamic therapy through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.